FDA Clears Golimumab Biosimilars

• by Kathryn Wighton

• May 18, 2026

Foot and ankle pain in rheumatoid arthritis: the symptom is the signal, the underlying pathology the treatment target

• by Akihisa Haraguchi, Tomomasa Kuga, Shintaro Kaneda, Kenta Kamo

• September 28, 2026

Autoantibodies to Joint-Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals

• by Outi Sareila, Linda Johansson, Anders Lundquist, Monica Leu Agelii, Lei Cheng, Yibo He, Erik Lönnblom, Maria Andersson, Jan Kihlberg, Anders Esberg, Inger Gjertsson, Rikard Holmdahl, Solbritt Rantapää-Dahlqvist

• May 27, 2026

CD19 CAR T Therapy Tested in Refractory Rheumatoid Arthritis

Disease activity fell in all six participants in a phase I trial, with three achieving sustained drug-free remission during follow-up

• September 8, 2026

• 3 min